Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,371 across all filing types
Latest filing 2025-05-28 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT ON PARTICIPATION IN THE 2024 ANNUAL COLLECTIVE RESULTS PRESENTATION FOR THE SHANGHAI STOCK EXCHANGE MAIN BOARD HIGH DIVIDEND AND STRONG RETURNS THEME
Regulatory Filings Classification · 1% confidence The document is a short (3,881 characters) announcement informing investors about the Company’s participation in an upcoming ‘collective results presentation’ hosted by the Shanghai Stock Exchange. It does not contain financial results, slides, or the actual presentation materials—it merely notifies investors of the event timing, format, and participation details. This does not fit as an earnings release (ER), interim or annual report (IR, 10-K), investor presentation deck (IP), or any other specific category. As a miscellaneous regulatory notice it best fits the fallback category “Regulatory Filings” (RNS).
2025-05-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-05-22 English
DOCUMENTS ON DISPLAY
M&A Activity Classification · 1% confidence The document is a landing page or index from the HKEX news portal regarding a 'Discloseable and Connected Transaction' involving an acquisition of equity interest. It lists multiple attached PDF files, including agreements, valuation reports, and letters of consent. Since the document itself is a summary announcement providing links to these specific transaction-related documents, it falls under M&A Activity (TAR) as it pertains to the acquisition of equity interest.
2025-05-15 English
Revised Form of Proxy (the "New Form of Proxy") for Use at the Annual General Meeting for the Year Ended 31 December 2024 to be held on Friday, 30 May 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a revised proxy form to be used by shareholders to appoint proxies and vote on resolutions at the upcoming Annual General Meeting. It is part of the proxy solicitation materials sent to shareholders to request their votes. This fits the definition of a Proxy Solicitation & Information Statement rather than an AGM presentation or an annual report.
2025-05-15 English
Circular
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular including extensive explanatory information, transaction details, connected transactions, letters from the board, appendices and a supplemental notice of the 2024 AGM, together with proxy instructions. It is clearly a proxy solicitation/information statement sent to shareholders to request votes and provide detailed background on resolutions to be considered at the Annual General Meeting. This matches the Proxy Solicitation & Information Statement category (PSI).
2025-05-15 English
SUPPLEMENTAL NOTICE OF 2024 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a supplement to the formal notice of the 2024 Annual General Meeting of Yankuang Energy Group Company Limited. It details the resolutions to be tabled, proxy instructions, and voting procedures – i.e., materials sent to shareholders to provide information and solicit their votes at the AGM. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2025-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.